Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II, Randomized, Multi-site Trial to Investigate the Efficacy and Safety of BNT314 in Combination With Pumitamig and Chemotherapy in Participants With Metastatic Colorectal Cancer

NCT07079631 is registered in ClinicalTrials.gov with BioNTech SE as lead sponsor.

NCT NCT07079631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07079631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II, Randomized, Multi-site Trial to Investigate the Efficacy and Safety of BNT314 in Combination With Pumitamig and Chemotherapy in Participants With Metastatic Colorectal Cancer
Lead sponsor
BioNTech SE
Phase
Phase 1/2
Overall status
Recruiting
Start date
July 18, 2025
Completion date
December 31, 2032
Enrollment
482 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer